Ritu Salani

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 2

Top Topics

Placebo Controlled

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

This page only lists publications with an associated author ORCID identifier.

Publications

Ritu Salani, Mary McCormack, Yong-Man Kim, Sharad Ghamande, Shaundra L Hall, Domenica Lorusso, Lisa Barraclough, Lucy Gilbert, Adrian Guzman Ramirez, Chien-Hsing Lu, Renaud Sabatier, Nicoletta Colombo, Youyou Hu, Venkatesh Krishnan, Luciana Molinero, Yuning Feng, Nicole Kim, Marcela Castro, Yvonne G Lin, Bradley J Monk
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (8) (2024)
Ritu Salani, Mary McCormack, Yong-Man Kim, Sharad Ghamande, Shaundra L Hall, Domenica Lorusso, Lisa Barraclough, Lucy Gilbert, Adrian Guzman Ramirez, Chien-Hsing Lu, Renaud Sabatier, Nicoletta Colombo, Youyou Hu, Venkatesh Krishnan, Luciana Molinero, Yuning Feng, Nicole Kim, Marcela Castro, Yvonne G Lin, Bradley J Monk
A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)